Low price for (R)-(+)-BINOL - (1S,2R)-(-)-1-Amino-2-indanol CAS 126456-43-7 Purity ≥99.0% E.E. ≥99.0% Indinavir Sulfate Intermediate – Ruifu
Low price for (R)-(+)-BINOL - (1S,2R)-(-)-1-Amino-2-indanol CAS 126456-43-7 Purity ≥99.0% E.E. ≥99.0% Indinavir Sulfate Intermediate – Ruifu Detail:
Manufacturer with High Quality and Competitive Price
Commercial Supply Indinavir Sulfate (CAS: 157810-81-6) Related Intermediates:
(1R,2S)-(+)-1-Amino-2-indanol CAS: 136030-00-7
(1S,2R)-(-)-1-Amino-2-indanol CAS: 126456-43-7
Chemical Name | (1S,2R)-(-)-1-Amino-2-indanol |
Synonyms | (1S,2R)-(-)-1-Amino-2-hydroxyindan |
CAS Number | 126456-43-7 |
CAT Number | RF-CC120 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C9H11NO |
Molecular Weight | 149.19 |
Solubility (Soluble in) | Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Pale Yellow Powder |
Specific Rotation [α]D20 | -47.0°~ -42.0° (C=1,MeOH) |
Melting Point | 115.0~121.0℃ |
Purity / Analysis Method | ≥99.0% (HPLC) |
Loss on Drying | ≤0.50% |
Moisture (K.F) | ≤0.50% |
E.E | ≥99.0% |
Test Standard | Enterprise Standard |
Usage | Indinavir Sulfate (CAS: 157810-81-6) Intermediates |
Package: Bottle, Cardboard Drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Manufacturer with High Quality and Competitive Price
Commercial Supply Indinavir Sulfate (CAS: 157810-81-6) Related Intermediates:
(1R,2S)-(+)-1-Amino-2-indanol CAS: 136030-00-7
(1S,2R)-(-)-1-Amino-2-indanol CAS: 126456-43-7
The Indinavir Sulfate (CAS: 157810-81-6) is an organic compound with the formula C36H47N5O4.H2SO4. The chemical name is (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide; sulfuric acid. With the CAS registry number 157810-81-6. The product’s categories are Active Pharmaceutical Ingredients; Anti-viral Compounds; Anti-virals; Inhibitors; Intermediates & Fine Chemicals; Non-nucleoside Reverse Transcriptase; Pharmaceuticals; Indinavir. Besides, it is a protease inhibitor used as a component of highly active antiretroviral therapy (HAART) to treat HIV infection and AIDS.
Indinavir(MK-639) is a protease inhibitor used as a component of highly active antiretroviral therapy (HAART) to treat HIV infection and AIDS.MK-639 appears to have significant dose-related antiviral activity and is well tolerated.
Indinavir (Crixivan) is a potent inhibitor of HIV reverse transcriptase. It produces the side effects common to all protease inhibitors and also may produce nephrolithiasis, urolithiasis, and possibly renal insufficiency or renal failure. This problem occurs more frequently in children (approximately 30%) than adults (approximately 10%) and can be minimized by drinking at least 1.5 L of water daily. Additional side effects include asymptomatic hyperbilirubinemia, alopecia, ingrown toenails, and paronychia. Hemolytic anemia rarely occurs. Rifampin should not be given with indinavir.
Product detail pictures:
Related Product Guide:
Our mission will be to grow to be an innovative supplier of high-tech digital and communication devices by giving worth added design and style, world-class production, and service capabilities for Low price for (R)-(+)-BINOL - (1S,2R)-(-)-1-Amino-2-indanol CAS 126456-43-7 Purity ≥99.0% E.E. ≥99.0% Indinavir Sulfate Intermediate – Ruifu , The product will supply to all over the world, such as: Greek, Luxemburg, Bulgaria, We are confident that we are able to provide you with opportunities and will be a valuable business partner of you. We look forward to working with you soon. Learn more about the types of products that we work with or contact us now directly with your inquiries. You are welcome to contact us anytime!
By Edwina from Montreal - 2018.02.21 12:14
This is a very professional wholesaler, we always come to their company for procurement, good quality and cheap.
By Quintina from Niger - 2018.06.18 19:26